Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma

BACKGROUND: We examine the potential value of a series of clinically relevant PI3K-mTOR inhibitors alone, or in combination with histone deacetylase inhibitors, in a model of head and neck squamous cell carcinoma (HNSCC). METHODS: Head and neck squamous cell carcinoma cell lines, human keratinocyte...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Erlich, R B, Kherrouche, Z, Rickwood, D, Endo-Munoz, L, Cameron, S, Dahler, A, Hazar-Rethinam, M, de Long, L M, Wooley, K, Guminski, A, Saunders, N A
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2012
Soggetti:
Translational Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251846/
https://ncbi.nlm.nih.gov/pubmed/22116303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.495
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi